Reports on the failure of a clinical trial testing BC 007, an infusion drug, for Long COVID, despite some individual patients reporting improvement. Uses the trial's outcome to examine problems with how Long COVID drug trials are designed and what researchers are learning for future studies.
Treatment & Management
A Rare Drug Trial for Long Covid Failed, Yielding Lessons on Study Design
July 22, 2025
Reports on the failure of a BC 007 infusion drug trial for Long COVID and what researchers are learning for future trial design.
Save For Later
Email yourself a link to this article.
Saved. Check your email app.
Something didn't go through — try again.